Hospital Variation in Premature Clopidogrel Discontinuation After Drug-Eluting Stent Placement in the Veterans Affairs (VA) Healthcare System

被引:4
|
作者
Vigen, Rebecca [1 ]
Maddox, Thomas M. [2 ,3 ,4 ]
O'Donnell, Colin I. [2 ]
Grunwald, Gary K. [2 ,3 ]
Bhatt, Deepak L. [5 ,6 ]
Tsai, Thomas T. [2 ,3 ,4 ]
Rumsfeld, John S. [2 ,3 ,4 ]
Ho, P. Michael [2 ,3 ,4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] VA Eastern Colorado Hlth Care Syst, 1055 Clermont St,Res A151, Denver, CO 80220 USA
[3] Univ Colorado Denver, Aurora, CO USA
[4] CCOR Consortium, Denver, CO USA
[5] Brigham & Womens Hosp, VA Boston Healthcare Syst, 75 Francis St, Boston, MA 02115 USA
[6] Harvard Med Sch, Boston, MA USA
来源
关键词
adherence; clopidogrel; drug-eluting stents; CARDIOVASCULAR-DATA-REGISTRY; ANTIPLATELET THERAPY; PREDICTORS; IMPLANTATION; PREVALENCE;
D O I
10.1161/JAHA.114.001376
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Premature clopidogrel discontinuation after drug-eluting stent placement is associated with adverse outcomes. Little is known about patient and hospital factors associated with premature discontinuation or whether less variation in premature discontinuation exists in integrated health care systems such as the Veterans Affairs (VA). Methods and Results-We evaluated the frequency of premature clopidogrel discontinuation, defined as a gap between clopidogrel refills of >= 90 days during the first 6 months of treatment, among 12 707 patients who received drug-eluting stents in VA hospitals between 2008 and 2010. We evaluated the association between premature discontinuation and all-cause mortality and/or acute myocardial infarction, variation in the proportion of premature discontinuation among hospitals, the patient and hospital characteristics associated with premature discontinuation, and the extent to which unexplained hospital characteristics contribute to premature discontinuation. Of the patients, 963 (7.6%) discontinued clopidogrel prematurely. Premature discontinuation was associated with acute myocardial infarction and all-cause mortality (hazard ratio 1.65, 95% CI 1.37-1.99, P<0.001). The proportion of patients with premature discontinuation varied across hospitals from 0% to 16.5% (P<0.001). We found a median of 24% greater odds of patients with identical covariates with premature discontinuation at one randomly selected hospital compared with another (median odds ratio 1.24, 95% CI 1.17-1.44). Patient factors associated with premature discontinuation included lack of cardiology follow-up within 30 days of discharge and smaller initial clopidogrel fill. Conclusion-One in 13 patients prematurely discontinued clopidogrel, and variation in discontinuation across hospitals was observed. Patient factors were associated with premature discontinuation that may represent targets for quality improvement.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Temporal Course of Neointimal Formation After Drug-Eluting Stent Placement
    Finn, Aloke V.
    Nakazawa, Gaku
    Kolodgie, Frank D.
    Virmani, Renu
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) : 300 - 302
  • [22] Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation
    Decoene, C
    Vincentelli, A
    Fabre, O
    Crepin, F
    Pol, A
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2005, 24 (10): : 1275 - 1277
  • [23] The temporal relationship between clopidogrel cessation and stent thrombosis after drug-eluting stent implantation
    Waksman, R.
    Roy, P.
    Torguson, R.
    Pinto-Slottow, T.
    Steinberg, D.
    Smith, K.
    Xue, Z.
    Satler, L.
    Kent, K.
    Pichard, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 326 - 327
  • [24] Temporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation
    Roy, Probal
    Bonello, Laurent
    Torguson, Rebecca
    Okabe, Teruo
    Pinto, Tina L.
    Steinberg, Daniel H.
    Kaneshige, Kimberly
    Xue, Zhenyi
    Satler, Lowell F.
    Kent, Kenneth M.
    Suddath, William O.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (06): : 801 - 805
  • [25] Drug-eluting stent thrombosis after 2029 days of placement: longest ever reported interval between drug-eluting stent placement and very late thrombosis
    Akhtar, Muhammed
    Waked, Alain
    Bhat, Hilal
    Khalid, Mariam
    Teli, Sumaya
    Saiful, Faisal B.
    Lafferty, James
    Bhat, Tariq
    FUTURE CARDIOLOGY, 2011, 7 (06) : 745 - 748
  • [26] In-stent restenosis nine years after initial placement of a drug-eluting stent
    Hopkinson, Dennis A.
    Raje, Vikram
    Jovin, Ion S.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (01) : 26 - 28
  • [27] Stent Thrombosis After Drug-Eluting Stent Implantation: Incidence, Timing and Relation to Discontinuation of Clopidogrel Therapy Over a 4-Year Period
    Schulz, Stefanie
    Ellert, Julia
    Goedel, Julia
    Byrne, Robert A.
    Lijma, Rasuke
    Bruskina, Olga
    Pache, Juergen
    Mehilli, Julinda
    Schoemig, Albert
    Kastrati, Adnan
    CIRCULATION, 2008, 118 (18) : S898 - S898
  • [28] Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
    Schulz, Stefanie
    Schuster, Tibor
    Mehilli, Julinda
    Byrne, Robert A.
    Ellert, Julia
    Massberg, Steffen
    Goedel, Julia
    Bruskina, Olga
    Ulm, Kurt
    Schoemig, Albert
    Kastrati, Adnan
    EUROPEAN HEART JOURNAL, 2009, 30 (22) : 2714 - 2721
  • [29] Antiplatelet Therapy Discontinuation Following Drug-Eluting Stent Placement: Dangers, Reasons, and Management Recommendations
    Moussa, Issam D.
    Colombo, Antonio
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2009, 74 (07) : 1047 - 1054
  • [30] Clopidogrel desensitization is a safe, effective, and practical treatment for clopidogrel allergy after drug-eluting stent implantation
    Valencia, Rafael
    Price, Maithew J.
    Simon, Ronald
    von Tiehl, Karl
    Lee, Steve S.
    Wong, Garret B.
    Luddington, Katherine
    Gollapudi, Raghava R.
    Teirstein, Paul S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 206M - 206M